Harvard Health Blog

A new therapy for osteoporosis: Romosozumab

By , Contributor

About the Author

photo of David M. Slovik, MD

David M. Slovik, MD, Contributor

David M. Slovik, MD, is an endocrinologist at Massachusetts General Hospital (MGH) who specializes in osteoporosis, and an associate professor of medicine at Harvard Medical School. He is currently chief of the division of endocrinology at … See Full Bio
View all posts by David M. Slovik, MD


As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.

No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.

Free Healthbeat Signup

Get the latest in health news delivered to your inbox!

Sign Up